Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus versus mycophenolate effects on lipid metabolism and cardiovascular function in kidney transplant recipients
NL-OMON41053Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of everolimus and mycophenolate in kidney transplant (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Fasting serum lipid profile, Ectopic lipid accumulation in liver and 3 more. Planned start Sep 2014; status: not yet recruiting.
02
Drugs
everolimusmycophenolate
03
Conditions
kidney transplant
Beyond the preview
Go deeper on NL-OMON41053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41053.